Clinical Trials Browser

INDUSTRY × Solid Tumors × liposomal doxorubicin × Clear all

NCT00819221 2022-08-30

AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT01214668 2019-01-04

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

Phase 1 Completed

31 enrolled 17 charts

Other solid neoplasm

Solid Tumors